Main Article Content
using different techniques (physical mixing and solvent evaporation).The product was characterized by differential scanning calorimetry (DSC), X-ray diffraction (XRD) and in vitro dissolution rate studies. Phase solubility analysis was performed in aqueous solution for drug polymer interactions. DSC and XRD analysis demonstrated the conversion of felodipine to amorphous form with both physical mixture (PM) and SD. SD with PVA released 95% of the drug in 85 min as compared with 89% of drug released in 90 min by SD with PEG 6000.Thus, SD with both polymers increased drug release, particularly greater in the case of PVA than PEG 6000.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
Dollery C. editor. In: Therapeutic drugs. 2nd ed. New York: Churchill
Abernethy DR, Schwartz JB. Calcium-Antagonist Drugs. N Engl J Med
Blychert E, Edgar B, Elmfeldt D, Hedner T. A Population Pharmacokinetics
of Felodipine. Br J Clin Pharmacol 1997;31:15-24.
Budavari S. et al. editors. In: The Merck Index, Merck Research
Laboratories. 12th ed. INC, White House, N.J: Division of Merck and
company; 1996. p. 670.
Moffat AC, Osselton MD, Widdop B. Clarkeâ€™s Analysis of drugs. Vol. 2.
rd ed. Pharmaceutical Press; 2002. p. 1018-9.
Anzai K, Mizoguchi J, Yanagi T, Hirayama F, Arima H, Uekama K.
Improvement of dissolution properties of a new helicobacter
pylori eradicating agent (tg44) by inclusion complexation with
beta- yclodextrin. Chem Pharm Bull (Tokyo) 2007;55:1466-70.
Ki HM, Choi HK. The effect of meloxicam/ethanolamine salt
formation on percutaneous absorption of meloxicam. Arch Pharm Res
Barzegar-Jalali M, Nayebi AM, Valizadeh H, Hanaee J, Barzegar- alali
J A, Adibkia K, et al. Evaluation of in vitro-in vivo correlation and
anticonvulsive effect of carbamazepine after cogrinding with
microcrystalline cellulose. J Pharm Pharm Sci 2006;9:307-16.
Wang L, Cui FD, Hayase T, Sunada H. Preparation and evaluation of
solid dispersion for nitrendipine-carbopol and nitrendipine-hpmcp
systems using a twin screw extruder. Chem Pharm Bull (Tokyo)
Kim EJ, Chun MK, Jang JS, Lee IH, Lee KR, Choi HK. Preparation of a
solid dispersion of felodipine using a solvent wetting method. Eur J
Pharm Biopharm 2006;64:200-5.
Leonardi D, Barrera MG, Lamas MC, Saloman CJ. Development of
prednisolone: Polyehylene glycol 6000 Fast-release Tablets From
Solid Dispersions: Solid-State Characterization, Dissolution Behavior,
and Formulation Parameters. AAPS PharmSciTech 2007;8:E108.
Sammour OA, Hammad MA, Megrab NA, Zidan AS. Formulation and
optimization of mouth dissolve tablets containing rofecoxib solid
dispersion. AAPS PharmSciTech 2006;7:E55.
Vijaya Kumar SG, Mishra DN. Preparation, characterization and in vitro
dissolution studies of solid dispersion of meloxicam with peg 6000.
Yakugaku Zasshi 2006;126:657-64.
Serajjudin AT. Solid dispersion of poorly water soluble drugs: early
promises, subsequent problems and recent breakthroughs. J Pharm
Chawala G, Bansal AK. Improved dissolution of a poorly water soluble
drug in solid dispersions with polymeric and non-polymeric hydrophilic
additives. Acta Pharm 2008;58:257-74.